期刊文献+

含多烯紫杉醇方案治疗晚期食管癌的临床观察 被引量:2

Clinical Observation of Paclitaxe Regiment for Advanced Oesophageal Cancer
下载PDF
导出
摘要 目的:观察多烯紫杉醇(泰索帝)联合顺铂(DDP)和5-氟尿嘧啶(5-FU)方案治疗晚期食管癌的疗效和不良反应。方法:对46例晚期食管癌患者给予泰索帝175mg/m2,每3周1次;DDP75mg/m2,每3周1次,5-FU,500~700mg/m2,持续静脉滴入5d,每28d为1个周期,至少2个周期以上进行评价。结果:46例患者均完成所需周期化疗。其中6例CR,14例PR,有效率(CR+PR)为43.5%。常见治疗毒性为骨髓抑制(100%),消化道反应(26.1%),黏膜炎(32.6%)和脱发(56.5%)。结论:泰索帝联合DDP和5-氟尿嘧啶(5-Fu)方案治疗晚期食管癌有效,毒副反应可以耐受。 Objective: To observe the curative effect and adverse effect of paclitaxe(taxotere) plus cisplation(DDP) and 5-FU for advanced oesophageal cancer. Method: Forty-six patients were received taxotere 175 mg/m2 once per 3 weeks, DDP 75 mg/m2 once per 3 weeks, and 5-FU 500- 700 mg/m2, dl-dS, which 28 days was one cycle, and each patient should finish two cycles at least. All patients finished the treatment. Result: Six patients showed CR and fourteen patients showed PR among the 65 patients, giving an effective rate of 43.5%. The common adverse effect were bone marrow depression(100%), gastrointestinal effect(26.1%), blennymenitis(32.6%) and alopecia(56.5%). Conclusion: The regiment is effective in treating advanced oesophageal cancer with tolerable adverse effect.
作者 张海滟
出处 《中国医学创新》 CAS 2012年第27期104-105,共2页 Medical Innovation of China
关键词 紫杉醇 顺铂 食管癌 化疗 Paclitaxel Cisplatin Oesophagealcancer Chemotherapy
  • 相关文献

参考文献7

  • 1Ajani J A. Treatment of patients with upper gastrointestinal carcinoma[J]. Seruim Oncol, 1997, 24(6 suppl 19):1872. 被引量:1
  • 2Ohtsu A, Shiral K, Miyata Y, et al. A phase 1] study of three- hour infusion paclitaxe! in patients with advanced gastric cancer[J]. Proceeding of ASCO, 2000, 10(19):303. 被引量:1
  • 3Rischin D, Boyer M, Smith J, et al. A phase I trial of docetaxel and gemcitabine in patients with advanced cancer[J]. Ann Oncol, 2000, 11(4):421-426. 被引量:1
  • 4李瑛,石廷章,赵卫红.泰素帝诱导人肺腺癌细胞凋亡的实验研究[J].中华肿瘤杂志,2000,22(3):208-211. 被引量:34
  • 5i Extra J M, Rousseau F, Bruno R, et al. Phase I and phamacokinetic study of Taxotere(RP 5697 ; NSC 625503) give as a short intravenous infusion[J]. Cancer Res, 1993, 53(5):1037-1042. 被引量:1
  • 6Fossella F V. Docetaxel for previously treated non-small-cell lung cancer[J]. Oncology, 2002, 16(supp16):45-51. 被引量:1
  • 7Kim Y H, Shin S W, Kim B S, et al. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J]. Cancer, 1999, 85(2):295-302. 被引量:1

二级参考文献3

  • 1Rita C,J Clin Oncol,1998年,16卷,907页 被引量:1
  • 2Ferlini C,Br J Cancer,1997年,75期,884页 被引量:1
  • 3卢圣栋,现代分子生物学实验技术,1993年,103页 被引量:1

共引文献33

同被引文献26

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部